Advertisement
AD

Main navigation

Theranos Stock Certificate to Be Sold as NFT by Early Investor

Advertisement
Thu, 16/12/2021 - 20:27
Theranos Stock Certificate to Be Sold as NFT by Early Investor
Cover image via www.flickr.com
Read U.TODAY on
Google News

American entrepreneur Marc Ostrofsky, who was among early investors in the infamous biotech scam Theranos, now wants to make his money back by auctioning his Series A stock certificate signed by none other than Elizabeth Holmes as a non-fungible token.

Aptly named “The Rise and Fall of Theranos,” the NFT has appeared on the OpenSea marketplace with a starting bid of 1 ether ($4,044).  

The winner will be able to redeem the token for the physical certificate.

The auction will last until Dec. 23, the final day of jury deliberation before Christmas.       

Ostrofsky says that he has issued the NFT to take advantage of opportunities presented by the new technology:

Advertisement

Over the course of my career, I've tried to continually identify hot new trends in the marketplace to capture the 'first mover' advantage.

He put $100,000 into Theranos during the company’s Series A funding round.

Related
Shiba Inu Goes Live on Taiwan's Leading Crypto Exchange
In 2015, the former darling of Silicon Valley investors reached its peak valuation of $10 billion, with Holmes becoming America’s wealthiest and youngest self-made female billionaire.

However, an investigation initiated by Wall Street Journal’s John Carreyrou led to the demise of the startup, whose revolutionary blood-testing technology turned out to be a sham.

During seven days of testimony, Holmes was attempting to pin the blame on former Theranos president Ramesh “Sunny” Balwani, who was also her boyfriend. Relying on the Svengali defense, she painted Balwani as an abuser who controlled her life.  
 

The jury will begin deliberating after the conclusion of closing arguments in the case on Dec. 17.

Advertisement
TopCryptoNewsinYourMailbox
TopCryptoNewsinYourMailbox
Advertisement

Latest Press Releases

Our social media
There's a lot to see there, too

Popular articles

Advertisement
AD